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eTable 1. Psychiatric Medications by Category and Class 
Antidepressants Antipsychotics Lithium Salts Sedatives/Anxiolytics Stimulants 
     
Selective Serotonin Reuptake 
Inhibitors (SSRIs) Atypical Antipsychotics Lithium Salts Short-Acting Benzodiazepines Amphetamines 
Citalopram Aripiprazole Lithium Alprazolam Amphetamine 
Escitalopram Clozapine  Clobazam Amphetamine / 
Dextroamphetamine Fluoxetine Fluoxetine/Olanzapine  Clonazepam 
Fluoxetine/Olanzapine Olanzapine  Estazolam Dexmethylphenidate 
Fluvoxamine Paliperidone  Lorazepam Dextroamphetamine 
Paroxetine Quetiapine  Midazolam Lisdexamfetamine 
Dimesylate Sertraline Risperidone  Oxazepam 
SSRIs, NOS Ziprasidone  Temazepam Methamphetamine 
    Triazolam Methylphenidate 
Serotonin/Norepinephrine Typical Antipsychotics   Amphetamines, NOS 
Reuptake Inhibitors (SNRIs) Chlorpromazine  Non-Benzodiazpines  
Desvenlafaxine Fluphenazine  Buspirone Miscellaneous 
Duloxetine Haloperidol  Butabarbital Stimulants 
Milnacipran Haloperidol/Fluphenazine  Chloral Hydrate Armodafinil 
Venlafaxine Loxapine  Eszopiclone Atomoxetine 
  Perphenazine  Meprobamate Modafinil 
Triazolpyridines Amitriptyline/Perphenazine  Phenobarbital Stimulants, NOS 
Trazodone Thioridazine  Ramelteon   
  Thiothixene  Secobarbital   
Aminoketones Trifluoperazine  Zaleplon   
Bupropion   Zolpidem   
    Barbituric Acid Derivatives, 
NOS 
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eTable 1. Psychiatric Medications by Category and Class 
Antidepressants Antipsychotics Lithium Salts Sedatives/Anxiolytics Stimulants 
     
Tricyclic Antidepressants Miscellaneous Antipsychotics  Long-Acting Benzodiazepines  
Amitriptyline Pimozide  Chlordiazepoxide  
Amitriptyline/Chlordiazepoxide Antipsychotics, NOS  Amitriptyline/Chlordiazepoxide  
Amitriptyline/Perphenazine   Clorazepate  
Amoxapine   Diazepam  
Clomipramine  Flurazepam   
Desipramine  Quazepam   
Doxepin    
Imipramine  Miscellaneous  
Nortriptyline  Sedatives/Anxiolytics  
Protriptyline  Benzodiazepine   
Trimipramine  Derivatives, NOS  
Tricylic Antidepressants, NOS  Sedatives/Anxiolytics, NOS  
     
Tetracyclic Antidepressants    
Maprotiline    
Mirtazapine    
     
Monoamine Oxidase Inhibitors 
(MAOIs) 
 
  
Isocarboxazid    
Phenelzine Sulfate    
Selegiline    
Tranylcypromine    
MAOI, NOS    
      
Miscellaneous Antidepressants      
Nefazodone    
Antidepressants, NOS NOS - Not otherwise specified 
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eTable 2. Adverse Drug Effect by Category 
Abnormal Behavior or Mood Disturbance In Consciousness Muscular 
Abnormal Behavior Depressed Level Of Consciousness  Asthenia 
Aggression Encephalopathy  Dysarthria 
Agitation Lethargy  Dysphonia 
Anger Loss Of Consciousness Facial Paresis 
Anxiety Sedation  Hypotonia  
Bruxism Somnolence  Muscle Atrophy 
Crying Stupor Muscle Strain  
Decreased Activity Unresponsive To Stimuli  Muscle Tightness  
Decreased Appetite  Muscular Weakness  
Delusion Fall Or Head Injury Paresis  
Depression Fall  
Disturbance In Attention Head Injury Pain  
Drooling  Abdominal Discomfort 
Emotional Disorder Gastrointestinal Abdominal Pain  
Euphoric Mood Constipation Arthralgia  
Excessive Masturbation Diarrhoea Back Pain  
Homicidal Ideation Dry Mouth Burning Sensation  
Insomnia Dyspepsia  Chest Discomfort  
Irritability Dysphagia  Chest Pain  
Listless Epigastric Discomfort Dysuria  
Logorrhoea Gastritis  Ear Pain  
Mania Gastrooesophageal Reflux Disease  Eye Irritation  
Mood Altered Nausea  Eye Pain  
Mood Swings Stomach Discomfort  Facial Pain  
Nervousness Vomiting  Flank Pain  
Oral Intake Reduced  Headache  
Panic Attack Hypersensitivity Reaction Migraine  
Paranoia Anaphylactic Reaction Musculoskeletal Chest Pain 
Psychomotor Hyperactivity Angioneurotic Oedema Musculoskeletal Stiffness  
Psychomotor Retardation Dermatitis Myalgia  
Restlessness Dermatitis Allergic Neck Pain  
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eTable 2. Adverse Drug Effect by Category 
Abnormal Behavior or Mood (cont.) Hypersensitivity Reaction (cont.) Pain (cont.) 
Screaming Dermatitis Contact Oral Pain 
Self Injurious Behaviour Dermatitis Exfoliative Generalised Pain In Extremity  
Self Mutilation Drug Eruption Pain In Jaw  
Sluggishness Drug Hypersensitivity Pharyngolaryngeal Discomfort  
Suicidal Ideation Erythema Photophobia  
Tearfulness Eye Pruritus Throat Irritation  
 Face Oedema Toothache  
Abnormal Drug Level Lip Swelling  
Anticonvulsant Drug Level Abnormal Oedema Mouth Respiration
Anticonvulsant Drug Level Above Therapeutic Oedema Peripheral Apnoea 
Antidepressant Drug Level Above Therapeutic Oral Pruritus Cough 
Antidepressant Drug Level Increased Oropharyngeal Swelling Dyspnoea 
Antipsychotic Drug Level Above Therapeutic Periorbital Oedema Hyperventilation 
Antipsychotic Drug Level Increased Pharyngeal Oedema Hypoxia 
 Photosensitivity Allergic Reaction Oxygen Saturation Decreased 
Altered Mental Status Pruritus Respiratory Acidosis 
Akinaesthesia Pruritus Generalized Respiratory Depression 
Amnesia Rash Respiratory Distress 
Aphasia Rash Generalised Respiratory Failure 
Aphonia Rash Maculo-Papular Respiratory Rate Decreased 
Confusional State Rash Papular Wheezing 
Delirium Rash Pruritic  
Disorientation Rash Vesicular Sensory 
Formication Swelling Aphasia 
Hallucination Swelling Face Aphonia 
Hallucination, Auditory Swollen Tongue Balance Disorder 
Hallucination, Visual Tongue Eruption Diplopia 
Incoherent Tongue Oedema Dizziness 
Memory Impairment Urticaria Dysgeusia 
Mental Disorder Urticaria Generalized Feeling Abnormal 
Mental Impairment  Feeling Drunk 
Mental Status Changes  Feeling Hot 
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eTable 2. Adverse Drug Effect by Category 
Cardiovascular Movement Disorder or Spasticity Sensory (cont.) 
Blood Pressure Decreased Akathisia Feeling Jittery 
Blood Pressure Increased Blepharospasm Hypoaesthesia 
Bradycardia Coordination Abnormal Hypoaesthesia Facial 
Cardiac Arrest Dyskinesia Hypoaesthesia Oral 
Electrocardiogram QRS Complex Prolonged Dystonia Oral Dysaesthesia 
Electrocardiogram QT Prolonged Extrapyramidal Disorder Paraesthesia 
Extrasystoles Gait Disturbance Paraesthesia Oral 
Heart Rate Abnormal Hemiparesis Sensation Of Heaviness 
Heart Rate Increased Hypertonia Skin Burning Sensation 
Hypertension Laryngospasm Tinnitus 
Hypertensive Emergency Motor Dysfunction Vertigo 
Hypotension Movement Disorder Vision Blurred 
Palpitations Muscle Contractions Involuntary Visual Acuity Reduced 
Presyncope Muscle Rigidity Visual Disturbance 
Sinus Tachycardia Muscle Spasms  
Syncope Muscle Spasticity  
Tachycardia Muscle Twitching  
 Myoclonus  
 Oesophageal Spasm  
 Parkinsonism  
 Tardive Dyskinesia  
 Tic  
 Tongue Spasm  
 Torticollis  
 Tremor  
 Trismus  
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eTable 3. Numbers of Cases and National Estimates of Annual Emergency Department (ED) Visits for 
Psychiatric Medication Adverse Drug Events, by Patient Sex, Patient Age, and Medication Category–
United States, 2009-2011 
Sex, Age Group, and Psychiatric 
Medication 
ED Visits for Adverse Drug Eventsa 
Est. Annual ED Visits 
per 10,000 Outpatient 
Prescription Visitsb 
No. of 
Cases 
Est. Annual 
No. of 
Visits 
Proportion of Age 
Group Visits Hospitalization
Rate (%) No. (95% CI) 
% (95% CI) 
Females        
 19 to 44 years old         
     Sedatives/Anxiolytics 306 6,849 25.5 (22.4-28.7) 11.8 4.8 (4.1-5.5) 
     Antidepressants 400 9,710 36.2 (32.5-40.0) 5.5 4.5 (3.8-5.1) 
     Antipsychotics 306 6,861 25.6 (22.4-28.8) 8.0 16.2 (13.7-18.7) 
     Lithium Salts 41 773 2.9 (1.6-4.2) c 13.1 (9.0-17.1) 
     Stimulants 50 1,143 4.3 (3.0-5.5) c 4.0 (3.1-4.8) 
     Two drugs from different   
     psychiatric medication categories  71 1,474 5.5 (3.8-7.2) c Not applicable 
 45 to 64 years old      
     Sedatives/Anxiolytics 309 6,818 37.8 (34.4-41.2) 25.0 3.0 (2.5-3.4) 
     Antidepressants 215 5,218 28.9 (24.9-32.9) 11.8 1.7 (1.4-1.9) 
     Antipsychotics 143 3,048 16.9 (13.8-19.9) 24.0 6.2 (5.0-7.3) 
     Lithium Salts 66 1,157 6.4 (3.3-9.6) 55.0 20.7 (13.7-27.8) 
     Stimulant 5 c c c c 
     Two drugs from different  
     psychiatric medication categories 68 1,725 9.6 (7.4-11.7) 33.6 Not applicable 
≥65 years old      
     Sedatives/Anxiolytics 238 5,370 52.0 (46.4-57.6) 34.7 3.0 (2.6-3.5) 
     Antidepressants 136 3,122 30.2 (25.0-35.5) 25.2 1.6 (1.3-1.9) 
     Antipsychotics 56 1,329 12.9 (9.7-16.0) 30.0 6.2 (4.9-7.6) 
     Lithium Salts 15 c c c c 
     Stimulants 1 c c c c 
     Two drugs from different   
     psychiatric medication categories 9 c c c Not applicable 
Males        
  19 to 44 years old    
 Sedatives/Anxiolytics 190 4,053 23.5 (19.6-27.4) 15.3 5.1 (4.2-6.0) 
  Antidepressants 161 3,721 21.6 (17.5-25.7) 11.5 3.8 (3.1-4.5) 
 Antipsychotics 376 6,917 40.1 (34.4-45.9) 11.9 19.9 (16.7-23.1) 
 Lithium Salts 20 c c c c 
  Stimulants 57 1,334 7.7 (4.7-10.8) c 4.9 (3.5-6.4) 
  
Two drugs from different 
psychiatric medication 
categories  35 931 5.4 (3.7-7.1) c Not applicable 
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eTable 3. Numbers of Cases and National Estimates of Annual Emergency Department (ED) Visits for 
Psychiatric Medication Adverse Drug Events, by Patient Sex, Patient Age, and Medication Category–
United States, 2009-2011 
Sex, Age Group, and Psychiatric 
Medication 
ED Visits for Adverse Drug Eventsa 
Est. Annual ED Visits 
per 10,000 Outpatient 
Prescription Visitsb 
No. of 
Cases 
Est. Annual 
No. of 
Visits 
Proportion of Age 
Group Visits Hospitalization
Rate (%) No. (95% CI) 
% (95% CI) 
Males        
 45 to 64 years old   
 Sedatives/Anxiolytics 186 4,494 38.6 (33.7-43.5) 30.4 3.4 (2.8-3.9) 
  Antidepressants 122 2,663 22.9 (17.8-28.0) 21.0 1.8 (1.5-2.2) 
 Antipsychotics 141 2,813 24.2 (20.5-27.8) 18.6 7.6 (6.2-9.0) 
 Lithium Salts 43 949 8.1 (5.6-10.7) 69.7 27.3 (18.9-35.7) 
  Stimulant 11 c c c c 
  
Two drugs from different 
psychiatric medication 
categories 33 499 4.3 (2.4-6.1) c Not applicable 
 ≥65 years old   
 Sedatives/Anxiolytics 142 3,123 61.8 (55.8-67.9) 27.4 3.9 (3.3-4.6) 
  Antidepressants 42 942 18.7 (13.1-24.2) c 1.0 (0.8-1.3) 
 Antipsychotics 33 610 12.1 (7.1-17.1) c 4.3 (3.0-5.6) 
 Lithium Salts 12 c c c c 
  Stimulants 0 c c c c 
  
Two drugs from different 
psychiatric medication 
categories 9 c c c Not applicable 
a Number of cases and national estimates of ED visits from the National Electronic Injury Surveillance System–Cooperative 
Adverse Drug Event Surveillance (NEISS-CADES) project. The hospitalization rate is the ratio of ED visits resulting in admission, 
observation, or transfer to total ED visits for adverse drug events involving the specified medication category.  
b Estimated annual numbers of outpatient prescription visits for each medication category are from the National Ambulatory 
Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) for 2009 and 2010 and 
include outpatient prescription visits in which multiple psychiatric medications were prescribed at a single visit. 
c Statistically unreliable estimate 
 
 
 
 
 
 
 
 
